SSH1 and cancer: Despite this background understanding, if, how and to what extent SSH1 is involved tumor initiation, cancer metastasis, resistance to therapy, and poor prognosis remain largely under-explored, and more so compounded by our limited understanding of how the seemingly opposing actions of SSH1 are controlled in the context of the HCC microenvironment.